Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-37807 vs Timolol with Latanoprost in Glaucoma/OHT
NCT00620256Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AL-37807 in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Nov 2007; status: completed.
02
Drugs
AL-37807
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00620256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620256.